AMARIN CORP PLC\UK Research and Development Expense
AMARIN CORP PLC\UK (AMRN) reported Research and Development Expense of $4.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-29
- AMARIN CORP PLC\UK research and development expense for the quarter ending 2026-06-30 was $4.77M, a 2.89% decline year-over-year.
- AMARIN CORP PLC\UK research and development expense for the quarter ending 2026-03-31 was $4.67M, a 12.18% decline year-over-year.
- AMARIN CORP PLC\UK research and development expense for the quarter ending 2025-12-31 was $5.37M, a 10.26% decline year-over-year.
- AMARIN CORP PLC\UK research and development expense for the quarter ending 2025-09-30 was $4.21M, a 7.31% decline year-over-year.
- AMARIN CORP PLC\UK research and development expense for fiscal 2025 was $19.81M, a 5.09% decline from fiscal 2024.
- AMARIN CORP PLC\UK research and development expense for fiscal 2024 was $20.87M, a 6.08% decline from fiscal 2023.
- AMARIN CORP PLC\UK research and development expense for fiscal 2023 was $22.22M, a 26.94% decline from fiscal 2022.
- AMARIN CORP PLC\UK research and development expense for fiscal 2022 was $30.41M, a 3.77% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.77M 10-Q · filed 2026-07-29 | $9.44M 10-Q · filed 2026-07-29 | $14.81M derived: sum of 3 quarters · filed 2026-07-29 | $19.02M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $4.67M 10-Q · filed 2026-04-29 | $10.04M derived: sum of 2 quarters · filed 2026-04-29 | $14.24M derived: sum of 3 quarters · filed 2026-04-29 | $19.16M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $9.58M derived: sum of 2 quarters · filed 2026-03-02 | $14.49M derived: sum of 3 quarters · filed 2026-07-29 | $19.81M 10-K · filed 2026-03-02 |
| 2025-09-30 | $4.21M 10-Q · filed 2025-10-29 | $9.12M derived: sum of 2 quarters · filed 2026-07-29 | $14.44M 10-Q · filed 2025-10-29 | $20.42M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $4.92M 10-Q · filed 2026-07-29 | $10.23M 10-Q · filed 2026-07-29 | $16.21M derived: sum of 3 quarters · filed 2026-07-29 | $20.75M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $5.31M 10-Q · filed 2026-04-29 | $11.30M derived: sum of 2 quarters · filed 2026-04-29 | $15.84M derived: sum of 3 quarters · filed 2026-04-29 | $20.58M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $10.53M derived: sum of 2 quarters · filed 2026-03-02 | $15.27M derived: sum of 3 quarters · filed 2026-03-02 | $20.87M 10-K · filed 2026-03-02 |
| 2024-09-30 | $4.54M 10-Q · filed 2025-10-29 | $9.29M derived: sum of 2 quarters · filed 2025-10-29 | $14.88M 10-Q · filed 2025-10-29 | $20.68M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $4.75M 10-Q · filed 2025-07-30 | $10.34M 10-Q · filed 2025-07-30 | $16.14M derived: sum of 3 quarters · filed 2026-03-02 | $21.24M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $5.60M 10-Q · filed 2025-05-07 | $11.39M derived: sum of 2 quarters · filed 2026-03-02 | $16.49M derived: sum of 3 quarters · filed 2026-03-02 | $22.14M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $10.90M derived: sum of 2 quarters · filed 2026-03-02 | $16.54M derived: sum of 3 quarters · filed 2026-03-02 | $22.22M 10-K · filed 2026-03-02 |
| 2023-09-30 | $5.11M 10-Q · filed 2024-10-30 | $10.75M derived: sum of 2 quarters · filed 2024-10-30 | $16.43M 10-Q · filed 2024-10-30 | $21.67M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | $5.64M 10-Q · filed 2024-07-31 | $11.32M 10-Q · filed 2024-07-31 | $16.56M derived: sum of 3 quarters · filed 2025-03-12 | $22.33M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | $5.68M 10-Q · filed 2024-05-01 | $10.92M derived: sum of 2 quarters · filed 2025-03-12 | $16.68M derived: sum of 3 quarters · filed 2025-03-12 | $26.04M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $11.00M derived: sum of 2 quarters · filed 2025-03-12 | $20.36M derived: sum of 3 quarters · filed 2025-03-12 | $30.41M 10-K · filed 2025-03-12 |
| 2022-09-30 | $5.76M 10-Q · filed 2023-11-01 | $15.12M derived: sum of 2 quarters · filed 2023-11-01 | $25.17M 10-Q · filed 2023-11-01 | $30.93M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $9.36M 10-Q · filed 2023-08-02 | $19.41M 10-Q · filed 2023-08-02 | $25.16M derived: sum of 3 quarters · filed 2024-02-29 | $32.98M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $10.05M 10-Q · filed 2023-05-03 | $15.80M derived: sum of 2 quarters · filed 2024-02-29 | $23.62M derived: sum of 3 quarters · filed 2024-02-29 | $29.98M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $13.57M derived: sum of 2 quarters · filed 2024-02-29 | $19.93M derived: sum of 3 quarters · filed 2024-02-29 | $29.31M 10-K · filed 2024-02-29 |
| 2021-09-30 | $7.82M 10-Q · filed 2022-10-27 | $14.18M derived: sum of 2 quarters · filed 2022-10-27 | $23.55M 10-Q · filed 2022-10-27 | $32.06M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $6.36M 10-Q · filed 2022-08-03 | $15.73M 10-Q · filed 2022-08-03 | $24.24M derived: sum of 3 quarters · filed 2023-03-01 | $34.45M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $9.38M 10-Q · filed 2022-05-04 | $17.89M derived: sum of 2 quarters · filed 2023-03-01 | $28.09M derived: sum of 3 quarters · filed 2023-03-01 | $38.06M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $8.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $18.71M derived: sum of 2 quarters · filed 2023-03-01 | $28.68M derived: sum of 3 quarters · filed 2023-03-01 | $38.96M 10-K · filed 2023-03-01 |
| 2020-09-30 | $10.20M 10-Q · filed 2021-11-03 | $20.17M derived: sum of 2 quarters · filed 2021-11-03 | $30.45M 10-Q · filed 2021-11-03 | $41.55M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $9.97M 10-Q · filed 2021-08-05 | $20.25M 10-Q · filed 2021-08-05 | $31.34M derived: sum of 3 quarters · filed 2022-03-01 | $40.27M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $10.28M 10-Q · filed 2021-04-29 | $21.38M derived: sum of 2 quarters · filed 2022-03-01 | $30.30M derived: sum of 3 quarters · filed 2022-03-01 | $37.43M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $20.02M derived: sum of 2 quarters · filed 2022-03-01 | $27.15M derived: sum of 3 quarters · filed 2022-03-01 | $34.39M 10-K · filed 2022-03-01 |
| 2019-09-30 | $8.92M 10-Q · filed 2020-11-05 | $16.05M derived: sum of 2 quarters · filed 2020-11-05 | $23.30M 10-Q · filed 2020-11-05 | $35.20M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $7.13M 10-Q · filed 2020-08-04 | $14.37M 10-Q · filed 2020-08-04 | $26.28M derived: sum of 3 quarters · filed 2021-02-25 | $40.35M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $7.24M 10-Q · filed 2020-04-30 | $19.15M derived: sum of 2 quarters · filed 2021-02-25 | $33.22M derived: sum of 3 quarters · filed 2021-02-25 | $51.38M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $11.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $25.98M derived: sum of 2 quarters · filed 2021-02-25 | $44.14M derived: sum of 3 quarters · filed 2021-02-25 | $55.90M 10-K · filed 2021-02-25 |
| 2018-09-30 | $14.07M 10-Q · filed 2019-11-05 | $32.23M derived: sum of 2 quarters · filed 2019-11-05 | $43.99M 10-Q · filed 2019-11-05 | $55.94M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $18.16M 10-Q · filed 2019-07-31 | $29.92M 10-Q · filed 2019-07-31 | $41.87M derived: sum of 3 quarters · filed 2020-02-25 | $52.56M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $11.76M 10-Q · filed 2019-05-01 | $23.71M derived: sum of 2 quarters · filed 2020-02-25 | $34.40M derived: sum of 3 quarters · filed 2020-02-25 | $48.10M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $11.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $22.64M derived: sum of 2 quarters · filed 2020-02-25 | $36.34M derived: sum of 3 quarters · filed 2020-02-25 | $47.16M 10-K · filed 2020-02-25 |
| 2017-09-30 | $10.69M 10-Q · filed 2018-11-01 | $24.39M derived: sum of 2 quarters · filed 2018-11-01 | $35.21M 10-Q · filed 2018-11-01 | $45.39M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $13.69M 10-Q · filed 2018-08-01 | $24.52M 10-Q · filed 2018-08-01 | $34.69M derived: sum of 3 quarters · filed 2019-02-27 | $48.18M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $10.82M 10-Q · filed 2018-05-02 | $21.00M derived: sum of 2 quarters · filed 2019-02-27 | $34.49M derived: sum of 3 quarters · filed 2019-02-27 | $47.07M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $10.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $23.67M derived: sum of 2 quarters · filed 2019-02-27 | $36.24M derived: sum of 3 quarters · filed 2019-02-27 | $49.98M 10-K · filed 2019-02-27 |
| 2016-09-30 | $13.49M 10-Q · filed 2017-11-01 | $26.07M derived: sum of 2 quarters · filed 2017-11-01 | $39.80M 10-Q · filed 2017-11-01 | $53.15M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $12.58M 10-Q · filed 2017-08-02 | $26.31M 10-Q · filed 2017-08-02 | $39.66M derived: sum of 3 quarters · filed 2018-02-27 | $52.75M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $13.73M 10-Q · filed 2017-05-03 | $27.08M derived: sum of 2 quarters · filed 2018-02-27 | $40.17M derived: sum of 3 quarters · filed 2018-02-27 | $52.18M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $13.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $26.44M derived: sum of 2 quarters · filed 2018-02-27 | $38.45M derived: sum of 3 quarters · filed 2018-02-27 | $51.06M 10-K · filed 2018-02-27 |
| 2015-09-30 | $13.09M 10-Q · filed 2016-11-03 | $25.10M derived: sum of 2 quarters · filed 2016-11-03 | $37.72M 10-Q · filed 2016-11-03 | $50.15M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $12.01M 10-Q · filed 2016-08-04 | $24.62M 10-Q · filed 2016-08-04 | $37.06M derived: sum of 3 quarters · filed 2017-03-01 | $51.52M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $12.61M 10-Q · filed 2016-05-05 | $25.05M derived: sum of 2 quarters · filed 2017-03-01 | $39.51M derived: sum of 3 quarters · filed 2017-03-01 | $51.23M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $12.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $26.89M derived: sum of 2 quarters · filed 2017-03-01 | $38.62M derived: sum of 3 quarters · filed 2017-03-01 | $50.33M 10-K · filed 2017-03-01 |
| 2014-09-30 | $14.46M 10-Q · filed 2015-11-04 | $26.18M derived: sum of 2 quarters · filed 2015-11-04 | $37.89M 10-Q · filed 2015-11-04 | $54.49M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $11.73M 10-Q · filed 2015-08-06 | $23.43M 10-Q · filed 2015-08-06 | $40.04M derived: sum of 3 quarters · filed 2016-02-25 | $56.86M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $11.71M 10-Q · filed 2015-05-08 | $28.31M derived: sum of 2 quarters · filed 2016-02-25 | $45.13M derived: sum of 3 quarters · filed 2016-02-25 | $62.62M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $16.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $33.42M derived: sum of 2 quarters · filed 2016-02-25 | $50.91M derived: sum of 3 quarters · filed 2016-02-25 | $72.75M 10-K · filed 2016-02-25 |
| 2013-09-30 | $16.82M 10-Q · filed 2014-11-06 | $34.31M derived: sum of 2 quarters · filed 2014-11-06 | $56.15M 10-Q · filed 2014-11-06 | $75.37M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $17.49M 10-Q · filed 2014-08-07 | $39.33M 10-Q · filed 2014-08-07 | $58.55M derived: sum of 3 quarters · filed 2015-03-03 | $79.46M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $21.84M 10-Q · filed 2014-05-09 | $41.06M derived: sum of 2 quarters · filed 2015-03-03 | $61.97M derived: sum of 3 quarters · filed 2015-03-03 | $76.04M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $19.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $40.13M derived: sum of 2 quarters · filed 2015-03-03 | $54.20M derived: sum of 3 quarters · filed 2015-03-03 | $58.96M 10-K · filed 2015-03-03 |
| 2012-09-30 | $20.91M 10-Q · filed 2013-11-07 | $34.98M derived: sum of 2 quarters · filed 2013-11-07 | $39.73M 10-Q · filed 2013-11-07 | $45.69M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $14.07M 10-Q · filed 2013-08-08 | $18.82M 10-Q · filed 2013-08-08 | $24.77M derived: sum of 3 quarters · filed 2014-02-27 | $30.79M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $4.76M 10-Q · filed 2013-05-09 | $10.71M derived: sum of 2 quarters · filed 2014-02-27 | $16.72M derived: sum of 3 quarters · filed 2014-02-27 | $21.91M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $11.96M derived: sum of 2 quarters · filed 2014-02-27 | $17.15M derived: sum of 3 quarters · filed 2014-02-27 | $21.60M 10-K · filed 2014-02-27 |
| 2011-09-30 | $6.01M 10-Q · filed 2012-11-08 | $11.20M derived: sum of 2 quarters · filed 2012-11-08 | $15.65M 10-Q · filed 2012-11-08 | $23.10M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $5.19M 10-Q · filed 2012-08-08 | $9.64M 10-Q · filed 2012-08-08 | $17.09M derived: sum of 3 quarters · filed 2013-02-28 | $24.73M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $4.45M 10-Q · filed 2012-05-08 | $11.90M derived: sum of 2 quarters · filed 2013-02-28 | $19.54M derived: sum of 3 quarters · filed 2013-02-28 | $27.31M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $15.09M derived: sum of 2 quarters · filed 2013-02-28 | $22.86M derived: sum of 3 quarters · filed 2013-02-28 | $28.01M 10-K · filed 2013-02-28 |
| 2010-09-30 | $7.64M 10-Q · filed 2011-11-08 | $15.41M derived: sum of 2 quarters · filed 2011-11-08 | $20.57M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $7.77M 10-Q · filed 2011-08-09 | $12.92M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $20.89M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |